Mimi van der Leden
Family Medicine · Spring, TXNPI 1932166741
Payments from drug & device makers
What this record shows
That places this record below the midpoint for family medicine clinicians in TX, where the typical reported total is $436.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$2,567,678in research payments, 2019–2025
Across 10,727 payments — averaging $239.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$1.4M
- Pfizer$550K
- Janssen Research & Development, LLC$381K
- Sanofi Pasteur Inc.$177K
- Eli Lilly$21K
- Alnylam Pharmaceuticals Inc.$19K
- plus $11K from 1 others
How this compares
$0 in reported general payments places this provider in the 0th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Spring
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.